Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-14 Purchase | 2024-08-15 5:09 pm | Beyond Air Inc. | XAIR | Lucera Erick Director | 39,266 | $0.3964 | $15,565 | 43,608 (Direct) | View |
2024-05-20 Sale | 2024-05-22 4:30 pm | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 22,337 | $5.6142 | $125,404 | 116,829 (Direct) | View |
2023-03-16 Purchase | 2023-03-20 4:10 pm | Beyond Air Inc. | XAIR | Lucera Erick Director | 2,000 | $6.817 | $13,634 | 4,342 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-15 Option Award | 2024-07-17 4:30 pm | N/A 2034-07-15 | SAB Biotherapeutics Inc. | SABS | Lucera Erick Director | 20,000 | $0 | 20,000 (Direct) | View |
2024-03-20 Option Award | 2024-03-21 9:01 pm | N/A 2034-03-20 | Beyond Air Inc. | XAIR | Lucera Erick Director | 45,000 | $0 | 45,000 (Direct) | View |
2024-03-02 Option Award | 2024-03-05 8:06 pm | N/A 2034-03-01 | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 167,266 | $0 | 245,166 (Direct) | View |
2023-09-18 Option Award | 2023-09-20 2:54 pm | N/A 2033-09-13 | Bone Biologics Corp | BBLG | Lucera Erick Director | 85,763 | $0 | 88,059 (Direct) | View |
2023-05-17 Option Award | 2023-05-18 5:20 pm | N/A 2033-05-16 | Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER | 233,700 | $0 | 233,700 (Direct) | View |
2023-04-03 Option Award | 2023-04-05 5:01 pm | N/A 2033-04-03 | SAB Biotherapeutics Inc. | SABS | Lucera Erick Director | 25,000 | $0 | 25,000 (Direct) | View |
2023-03-29 Option Award | 2023-03-31 4:15 pm | N/A 2033-03-28 | Beyond Air Inc. | XAIR | Lucera Erick Director | 40,000 | $0 | 40,000 (Direct) | View |
2022-08-23 Option Award | 2023-03-08 06:20 am | N/A 2027-08-23 | Bone Biologics Corp | BBLG | Lucera Erick Director | 36,845 | $0 | 68,516 (Direct) | View |
2023-01-19 Disposition | 2023-01-19 5:11 pm | N/A 2030-01-05 | AVEO PHARMACEUTICALS INC. | AVEO | Lucera Erick Chief Financial Officer | 368,800 | $0 | 0 (Direct) | View |
2022-03-03 Option Award | 2022-03-07 08:33 am | N/A 2032-03-02 | Beyond Air Inc. | XAIR | Lucera Erick Director | 30,000 | $0 | 30,000 (Direct) | View |
2021-10-26 Option Award | 2022-02-28 06:02 am | 2021-12-31 2031-10-26 | Bone Biologics Corp | BBLG | Lucera Erick Director | 11,671 | $0 | 54,620 (Direct) | View |
2022-02-15 Option Award | 2022-02-17 5:00 pm | N/A 2032-02-15 | AVEO PHARMACEUTICALS INC. | AVEO | Lucera Erick Chief Financial Officer | 218,800 | $0 | 218,800 (Direct) | View |
Ownership | 2021-10-21 5:20 pm | 2021-10-15 2031-10-15 | Bone Biologics Corp | BBLG | Lucera Erick Director | 0 | $0 | 50,000 (Direct) | View |
2021-02-05 Option Award | 2021-04-16 4:05 pm | N/A 2031-02-05 | AVEO PHARMACEUTICALS INC. | AVEO | Lucera Erick Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-03-04 Option Award | 2021-03-08 7:57 pm | N/A 2031-03-03 | Beyond Air Inc. | XAIR | Lucera Erick Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-02-16 Exercise | 2021-03-03 5:50 pm | N/A N/A | Beyond Air Inc. | XAIR | Lucera Erick Director | 1,171 | $4.25 | 2,342 (Direct) | View |
2021-02-16 Exercise | 2021-03-03 5:50 pm | 2018-02-16 2021-02-16 | Beyond Air Inc. | XAIR | Lucera Erick Director | 1,171 | $0 | 2,342 (Direct) | View |
2020-01-06 Option Award | 2020-01-08 4:31 pm | N/A 2030-01-05 | AVEO PHARMACEUTICALS INC | AVEO | Lucera Erick Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |